ANTIANGIOGENIC GENE THERAPY WITH SOLUBLE VEGFR-2 AND TIE2 REDUCES THE GROWTH OF HUMAN OVARIAN CARCINOMA IN MICE

被引：0
|
作者：
Tuppurainen, L. [1 ]
Sallinen, H. [2 ]
Karvonen, A. [1 ]
Hakkarainen, H. [3 ]
Liimatainen, T. [3 ]
Hytonen, E. [1 ]
Hamalainen, K. [4 ]
Kosma, V. M. [4 ]
Anttila, M. [2 ]
Alitalo, K. [5 ,6 ]
Yla-Herttuala, S. [1 ]
机构：
[1] Univ Eastern Finland, AI Virtanen Inst Mol Sci, Dept Biotechnol & Mol Med, Kuopio, Finland
[2] Kuopio Univ Hosp, Dept Gynecol, SF-70210 Kuopio, Finland
[3] Univ Eastern Finland, NMR Res Grp, AI Virtanen Inst Mol Sci, Kuopio, Finland
[4] Kuopio Univ Hosp, Dept Pathol, SF-70210 Kuopio, Finland
[5] Univ Helsinki, Mol Canc Biol Lab, Biomedicum Helsinki, Helsinki, Finland
[6] Univ Helsinki, Haartman Inst, Helsinki, Finland
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2015年 / 25卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ESGO-1277
引用
收藏
页码：636 / 636
页数：1
相关论文
共 50 条
  • [1] Antiangiogenic Gene Therapy With Soluble VEGFR-1,-2, and-3 Reduces the Growth of Solid Human Ovarian Carcinoma in Mice
    Sallinen, Hanna
    Anttila, Maarit
    Narvainen, Johanna
    Koponen, Jonna
    Hamalainen, Kirsi
    Kholova, Ivana
    Heikura, Tommi
    Toivanen, Pyry
    Kosma, Veli-Matti
    Heinonen, Seppo
    Alitalo, Kari
    Yla-Herttuala, Seppo
    MOLECULAR THERAPY, 2009, 17 (02) : 278 - 284
  • [2] Antiangiogenic AAV2 gene therapy with a truncated form of soluble VEGFR-2 reduces the growth of choroidal neovascularization in mice after intravitreal injection
    Puranen, Jooseppi
    Koponen, Sanna
    Nieminen, Tiina
    Kanerva, Iiris
    Kokki, Emmi
    Toivanen, Pyry
    Urtti, Arto
    Yla-Herttuala, Seppo
    Ruponen, Marika
    EXPERIMENTAL EYE RESEARCH, 2022, 224
  • [3] Cotargeting of VEGFR-1 and -3 and angiopoietin receptor Tie2 reduces the growth of solid human ovarian cancer in mice
    H Sallinen
    M Anttila
    O Gröhn
    J Koponen
    K Hämäläinen
    I Kholova
    V-M Kosma
    S Heinonen
    K Alitalo
    S Ylä-Herttuala
    Cancer Gene Therapy, 2011, 18 : 100 - 109
  • [4] Cotargeting of VEGFR-1 and-3 and angiopoietin receptor Tie2 reduces the growth of solid human ovarian cancer in mice
    Sallinen, H.
    Anttila, M.
    Grohn, O.
    Koponen, J.
    Hamalainen, K.
    Kholova, I.
    Kosma, V-M
    Heinonen, S.
    Alitalo, K.
    Yla-Herttuala, S.
    CANCER GENE THERAPY, 2011, 18 (02) : 100 - 109
  • [5] Comparison of the prognosis indication of VEGFR-1 and VEGFR-2 and Tie2 receptor expression in breast carcinoma
    Meunier-Carpentier, S
    Dales, JP
    Djemli, A
    Garcia, S
    Bonnier, P
    Andrac-Meyer, L
    Lavaut, MN
    Allasia, C
    Charpin, C
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2005, 26 (04) : 977 - 984
  • [6] VEGF-A, VEGFR-1, VEGFR-2 and Tie2 levels in plasma of premature infants:: relationship to retinopathy of prematurity
    Pieh, C.
    Agostini, H.
    Buschbeck, C.
    Krueger, M.
    Schulte-Moenting, J.
    Zirrgiebel, U.
    Drevs, J.
    Lagreze, W. A.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2008, 92 (05) : 689 - 693
  • [7] The Tie2 antagonist rebastinib reduces ovarian cancer growth in a syngeneic murine model
    Gupta, Vijayalaxmi G.
    Roby, Katherine F.
    Pathak, Harsh B.
    Godwin, Andrew K.
    Gunewardena, Sumedha
    Khabele, Dineo
    BMC CANCER, 2025, 25 (01)
  • [8] Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2
    Lin, PN
    Buxton, JA
    Acheson, A
    Radziejewski, C
    Maisonpierre, PC
    Yancopoulos, GD
    Channon, KM
    Hale, LP
    Dewhirst, MW
    George, SE
    Peters, KG
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (15) : 8829 - 8834
  • [9] Tie2 in Tumor Endothelial Signaling and Survival: Implications for Antiangiogenic Therapy
    Tsai, Jeff H.
    Lee, William M. F.
    MOLECULAR CANCER RESEARCH, 2009, 7 (03) : 300 - 310
  • [10] Vascular endothelial growth factor receptor-2 ( VEGFr-2) genetic polymorphisms as predictors to antiangiogenic therapy
    Jurado, J., Sr.
    Ortega, J. A.
    Iglesias, P.
    Garcia-Puche, J. L.
    Belon, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345